Global Information
회사소개 | 문의 | 비교리스트

에피제네틱스 시장 : 분석, 규모, 점유율, 동향, 예측(2020-2026년)

Epigenetics Market, By Product, By Technology, By Application, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026

리서치사 AnalystView Market Insights
발행일 2020년 05월 상품 코드 937202
페이지 정보 영문 220 Pages
가격
US $ 3,250 ₩ 3,726,000 PDF (Single User Licence) help
1명만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 4,650 ₩ 5,331,000 PDF (5 User Licence) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. 인쇄 횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,650 ₩ 6,477,000 PDF (Enterprise User Licence) help
동일 기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 및 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다.
자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



에피제네틱스 시장 : 분석, 규모, 점유율, 동향, 예측(2020-2026년) Epigenetics Market, By Product, By Technology, By Application, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
발행일 : 2020년 05월 페이지 정보 : 영문 220 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

에피제네틱스(Epigenetics) 시장은 2018년에 68억 7000만 달러에 달했으며, 2020-2026년의 예측 기간 중 CAGR로 22.4%의 성장이 예측됩니다.

세계의 에피제네틱스 시장에 대해 조사분석했으며, 시장 개요, 시장 역학, 부문별 시장 분석, 경쟁 구도 등에 관한 정보를 정리하여 전해드립니다.

목차

제1장 에피제네틱스 시장의 개요

  • 조사 범위
  • 전제조건과 조사 방법

제2장 개요

제3장 에피제네틱스의 주요 시장 동향

  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 에피제네틱스 업계 분석

  • Porter의 산업 분석
  • 마케팅 전략 분석
  • 성장 전망 지도제작
  • 규제 프레임워크 분석
  • COVID-19의 영향 분석

제5장 에피제네틱스 시장 구도

  • 시장 점유율 분석
  • 주요 이노베이터
  • 내역 데이터 : 주요 제조업체별

제6장 에피제네틱스 시장 : 제품별

  • 개요
  • 키트
  • 시약
  • 기기
  • 서비스
  • 효소

제7장 에피제네틱스 시장 : 적응별

  • 개요
  • 종양학
  • 종양학 이외

제8장 에피제네틱스 시장 : 기술별

  • 개요
  • 히스톤 메틸화
  • DNA 메틸화
  • 히스톤 아세틸화
  • 마이크로 RNA 수식
  • 긴 비암호화 RNA
  • 크로마틴 구조

제9장 에피제네틱스 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제10장 주요 벤더 분석

제11장 애널리스트의 견해

제12장 부록

KSA 20.06.09

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Epigenetics market: Product Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Epigenetics market, by Product 2015-2026 (USD Million)
  • TABLE Epigenetics market: Application Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Epigenetics market, by Application 2015-2026 (USD Million)
  • TABLE Epigenetics market: Technology Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Epigenetics market, by Technology 2015-2026 (USD Million)
  • TABLE Epigenetics market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Epigenetics market, by Region 2015-2026 (USD Million)
  • TABLE North America Epigenetics market, by Country, 2015-2026 (USD Million)
  • TABLE North America Epigenetics market, by Product, 2015-2026 (USD Million)
  • TABLE North America Epigenetics market, by Application, 2015-2026 (USD Million)
  • TABLE North America Epigenetics market, by Technology, 2015-2026 (USD Million)
  • TABLE Europe Epigenetics market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Epigenetics market, by Product, 2015-2026 (USD Million)
  • TABLE Europe Epigenetics market, by Application, 2015-2026 (USD Million)
  • TABLE Europe Epigenetics market, by Technology, 2015-2026 (USD Million)
  • TABLE Asia Pacific Epigenetics market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Epigenetics market, by Product, 2015-2026 (USD Million)
  • TABLE Asia Pacific Epigenetics market, by Application, 2015-2026 (USD Million)
  • TABLE Asia Pacific Epigenetics market, by Technology, 2015-2026 (USD Million)
  • TABLE Latin America Epigenetics market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Epigenetics market, by Product, 2015-2026 (USD Million)
  • TABLE Latin America Epigenetics market, by Application, 2015-2026 (USD Million)
  • TABLE Latin America Epigenetics market, by Technology, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Epigenetics market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Epigenetics market, by Product, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Epigenetics market, by Application, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Epigenetics market, by Technology, 2015-2026 (USD Million)

List of Figures

  • FIGURE Epigenetics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Product segment market share analysis, 2019 & 2026
  • FIGURE Product segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Kits market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Whole Genomic Amplification Kit market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE ChIP Sequencing Kit market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE RNA Sequencing Kit market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Bisulfite Conversion Kit market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Reagents market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Instruments market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Services market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Enzymes market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Oncology market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Liquid Tumors market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Solid Tumors market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Non-oncology market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Metabolic Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Inflammatory Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cardiovascular Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Infectious Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Technology segment market share analysis, 2019 & 2026
  • FIGURE Technology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Histone Methylation market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE DNA Methylation market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Histone Acetylation market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE MicroRNA Modification market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Large Non-coding RNA market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Chromatin Structures market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Epigenetics market share and leading players, 2018
  • FIGURE Europe Epigenetics market share and leading players, 2018
  • FIGURE Asia Pacific Epigenetics market share and leading players, 2018
  • FIGURE Latin America Epigenetics market share and leading players, 2018
  • FIGURE Middle East and Africa Epigenetics market share and leading players, 2018
  • FIGURE North America market share analysis by country, 2018
  • FIGURE U.S. Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Epigenetics market share analysis by country, 2018
  • FIGURE Germany Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Epigenetics market share analysis by country, 2018
  • FIGURE India Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Epigenetics market share analysis by country, 2018
  • FIGURE Brazil Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Epigenetics market share analysis by country, 2018
  • FIGURE Saudi Arabia Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Epigenetics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

REPORT HIGHLIGHT

Epigenetics market was valued at USD 6.87 billion by 2018, growing with 22.4% CAGR during the forecast period, 2020-2026

Epigenetics is defined as an extension of genetics as well as developmental biology that involves the study of physiological and cellular trait variations initiated by environmental or external stimuli. Epigenetics deals with alterations in gene expression, caused by particular base pairs in RNA & DNA, which are "turned on" or "turned off", through chemical reactions differing to being affected by alterations in the nucleotide sequence. Epigenetics changes are influenced by different factors including disease state, surrounding environment, age, lifestyle, and others.

Market Dynamics

The growing prevalence of cancer & other chronic diseases and increasing geriatric population are the major factors driving the growth of the global epigenetics market. According to the World Health Organization (WHO), around 9.6 million deaths were recorded in 2018 all across the globe due to cancer. Besides, the presence of organizations such as the National Institute of Health (NIH), the National Cancer Institute (NIC), and International Human Epigenome Consortium (IHEC) is progressively influencing the growth of the overall market.

In addition, the increasing need to understand epigenetic modifications and the development of therapeutic solutions are anticipated to motivate these organizations to fund R&D programs, which will create lucrative growth opportunities in the overall market during the forecast period. However, high costs associated with manufacturing and prohibitive costs of molecular diagnostics are expected to hinder the market growth in the coming future.

Product Takeaway

Based on the products, the global epigenetics market is segmented into kits, reagents, enzymes, instruments, and services. Of these, the reagents segment dominated the overall market in 2019 as DNA and histone modifiers are the major types of reagents utilized for epigenetics. Buffers, nucleic acid analysis, electrophoresis, primers, histones, PCR, and antibodies are some of the common epigenetic reagents. The presence of the number of technology platform facilitates the analysis at gene, cellular levels of protein, which boosts innovation in the worldwide marketplace.

On the other hand, the kits product segment is anticipated to grow at the highest CAGR in the projected timeframe. The kits segment is further sub-segmented into whole genomic amplification kit, ChIP-sequencing kit, RNA sequencing kit, and bisulfite conversion kit. The growth of this segment is because various biotechnology companies manufacture of ready-to-use kits for detecting epigenetic modifications. In addition, the epigenetic diagnostics kits are used for diagnosis of disorders owing to epigenetic modifications during treatment and in early stages to check therapeutics efficacy.

Technology Takeaway

On the basis of technology, the overall market for epigenetics is categorized into histone methylation, DNA methylation, histone acetylation, microRNA modification, large non - coding RNA, and chromatin structures. Among these, the DNA methylation segment accounted for the majority of market share in 2019 and is estimated to grow at a significant rate during the forecast period. DNA methylation leads to inhibition of transcription as it is the covalent addition in cytosine ring of a methyl group. In addition, technological advancements are increasingly enabling assessment of locus, which is a specific DNA methylation on a wide scale of the genome.

On the other hand, the histone acetylation segment is anticipated to be the fastest-growing market throughout the forecast due to its enhanced efficacy owing to the introduction of new mechanisms. Moreover, histone acetylation is involved in the control of cellular procedures such as chromatin transcription & dynamics, gene silencing, the progression of the cell cycle, apoptosis, differentiation, DNA replication, DNA repair, nuclear import, and neuronal repression.

Application Takeaway

Based on the application, the worldwide epigenetics market is categorized into non-oncology and oncology. The oncology segment is further sub-segmented into solid and liquid tumors. Whereas, the non-oncology segment is further sub-segmented into metabolic, inflammatory, cardiovascular, and infectious diseases.

The oncology segment accounted for major market share in terms of revenue in 2019 owing to the growing prevalence of cancer all over the worldwide coupled with increasing cases of deaths due. In addition, potential commercialization and introduction of novel products are predicted to propel the segmental market growth during the forecast period. On the other hand, the non-oncology segment is projected to register the highest growth during the period of forecast owing to the rigorous R&D initiatives undertaken by biopharmaceutical companies and private institutions for identification of epigenetic markers. In addition, epigenetic modifications are being proved to be the base of various non-oncology disorders such as infectious diseases, neurodegenerative disorders, and metabolic disorders.

Regional Takeaway

Depending on the region, the global industry is divided into North America, Latin America, Asia Pacific, Middle East & Africa, and Europe. The North America region is anticipated to account for the largest market share during the forecast period. The governments in this region are boosting ongoing R&D activities on epigenetics by funding them. In addition, the presence of advanced and continual developments in the healthcare facilities in diagnostic processes are stimulating regional market growth.

Along with this, the Asia Pacific market for epigenetics is projected to grow at the fastest rate during the period of forecast owing to growing awareness regarding early diagnosis, increasing disposable income, availability of effective treatment, and high unmet clinical needs of patients in this region. Also, this region is considered as the most attractive destination for market players owing to the consistent increase in different types of cancer cases among the patient population.

COVID-19 Impact

The coronavirus has spread aggressively to develop into a global pandemic that involves more than 170 countries. This unprecedented situation has affected lives across the political, economic, and social sphere. The primary focus of researchers and biopharmaceutical industries is epigenetics, which aids in vaccine development because the coronavirus has no available cure.

Thus, a breakthrough at this time may benefit pharmaceutical industries' stock prices including epigenetics market. Advancements through research in the understanding the viral chromatin modification in lytic viruses have significantly opened a new window for host-virus interactions and viral antagonism, including genetic factors. This would, in turn, boost the worldwide epigenetics market growth significantly over the future period.

Key Vendor Takeaway

The major players operating in the global epigenetics industry include Roche Diagnostics, Eisai Co. Ltd., Thermo Fisher Scientific, Inc., Novartis AG, Illumina, Inc., Qiagen, Merck Sharp & Dohme Corp, AbCam Plc, Diagenode Diagnostics, Activ Motif, Zymo Research Corporation, Syndax, Cell Centric, Valirx, and Oncolys BioPharma Inc. These players are adopting several strategies such as acquisitions, mergers, and novel product developments to hold a strong market position.

For instance, in February 2018, QIAGEN launched its novel therascreen PITX2 RGQ PCR Kit in Europe, which is the first clinically validated assay of DNA methylation that helps in predicting the response of particular high-risk breast cancer patients.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EPIGENETICS MARKET KEY PLAYERS

Roche Diagnostics

Eisai Co. Ltd.

Thermo Fisher Scientific, Inc.

Novartis AG

Illumina, Inc.

Qiagen

Merck Sharp & Dohme Corp

Abcam Plc

Diagenode Diagnostics

Activ Motif

Zymo Research Corporation

Syndax

Cell Centric

Oncolys BioPharma Inc.

GLOBAL EPIGENETICS MARKET, BY PRODUCT

Kits

Whole Genomic Amplification Kit

ChIP Sequencing Kit

RNA Sequencing Kit

Bisulfite Conversion Kit

Others

Reagents

Instruments

Services

Enzymes

GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY

Histone Methylation

DNA Methylation

Histone Acetylation

MicroRNA Modification

Large Non-coding RNA

Chromatin Structures

GLOBAL EPIGENETICS MARKET, BY APPLICATION

Non-oncology

Metabolic Diseases

Inflammatory Diseases

Cardiovascular Diseases

Infectious Diseases

Others

Oncology

Liquid Tumors

Solid Tumors

GLOBAL EPIGENETICS MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. EPIGENETICS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Product
    • 2.1.2. Market Snippet by Application
    • 2.1.3. Market Snippet by Technology
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. EPIGENETICS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. EPIGENETICS INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. EPIGENETICS MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. EPIGENETICS MARKET - BY PRODUCT

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
  • 6.2. Kits
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.1. Whole Genomic Amplification Kit
      • 6.2.2.1.1. Overview
      • 6.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.2. ChIP Sequencing Kit
      • 6.2.2.2.1. Overview
      • 6.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.3. RNA Sequencing Kit
      • 6.2.2.3.1. Overview
      • 6.2.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.4. Bisulfite Conversion Kit
      • 6.2.2.4.1. Overview
      • 6.2.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.5. Others
      • 6.2.2.5.1. Overview
      • 6.2.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Reagents
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Instruments
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.5. Services
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.6. Enzymes
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. EPIGENETICS MARKET - BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 7.2. Oncology
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.2.2.1. Liquid Tumors
      • 7.2.2.1.1. Overview
      • 7.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.2.2.2. Solid Tumors
      • 7.2.2.2.1. Overview
      • 7.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Non-oncology
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.3.2.1. Metabolic Diseases
      • 7.3.2.1.1. Overview
      • 7.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.3.2.2. Inflammatory Diseases
      • 7.3.2.2.1. Overview
      • 7.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.3.2.3. Cardiovascular Diseases
      • 7.3.2.3.1. Overview
      • 7.3.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.3.2.4. Infectious Diseases
      • 7.3.2.4.1. Overview
      • 7.3.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 7.3.2.5. Others
      • 7.3.2.5.1. Overview
      • 7.3.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. EPIGENETICS MARKET - BY TECHNOLOGY

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
  • 8.2. Histone Methylation
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. DNA Methylation
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Histone Acetylation
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. MicroRNA Modification
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.6. Large Non-coding RNA
    • 8.6.1. Overview
    • 8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.7. Chromatin Structures
    • 8.7.1. Overview
    • 8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. EPIGENETICS MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.2.8. Canada
      • 9.2.8.1. Overview
      • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 9.3.7. Germany
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.9. United Kingdom
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.10. France
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.11. Rest of Europe
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.11. Rest of APAC
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 9.5.5. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Roche Diagnostics
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. Eisai Co. Ltd.
  • 10.3. Thermo Fisher Scientific, Inc.
  • 10.4. Novartis AG
  • 10.5. Illumina, Inc.
  • 10.6. Qiagen
  • 10.7. Merck Sharp & Dohme Corp
  • 10.8. AbCam Plc
  • 10.9. Diagenode Diagnostics
  • 10.10. Activ Motif
  • 10.11. Zymo Research Corporation
  • 10.12. Syndax
  • 10.13. Cell Centric
  • 10.14. Valirx
  • 10.15. Oncolys BioPharma Inc.

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
Back to Top
전화 문의
F A Q